학술논문
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238
Document Type
Article
Author
Larkin, J.; Del Vecchio, M.; Mandalá, M.; Gogas, H.; Fernandez, A.M.A.; Dalle, S.; Cowey, C.L.; Schenker, M.; Grob, J.-J.; Chiarion-Sileni, V.; Marquez-Rodas, I.; Butler, M.O.; Di Giacomo, A.M.; Middleton, M.R.; Lutzky, J.; de la Cruz-Merino, L.; Arenberger, P.; Atkinson, V.; Hill, A.G.; Fecher, L.A.; Millward, M.; Nathan, P.D.; Khushalani, N.I.; Queirolo, P.; Ritchings, C.; Lobo, M.; Askelson, M.; Tang, H.; Dolfi, S.; Ascierto, P.A.; Weber, J.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 September 2023, 29(17):3352-3361)
Subject
Language
English
ISSN
15573265
10780432
10780432